{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T13:29:42Z","timestamp":1709472582244},"posted":{"date-parts":[[2023,7,5]]},"group-title":"In Review","reference-count":33,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Background\n Rheumatoid arthritis is a chronic systemic autoimmune disease that involves transformation of the lining of synovial joints into an invasive and destructive tissue. Synovial fibroblasts become transformed, invading and destroying bone and cartilage of the affected joint(s). Due to the significant role these cells play in the progression of the disease process, developing a therapeutic strategy to target and inhibit their invasive destructive nature could help patients who are afflicted with this debilitating disease. Gingival-derived mesenchymal stem cells are known to possess immunomodulatory properties and have been studied extensively as potential cell-based therapeutics for several autoimmune disorders.\nMethods\n A chimeric human\/mouse model of synovitis was created by surgically implanting SCID mice with a piece of human articular cartilage surrounded by RASF. Mice were injected once with either GMSC or GMSCExo at 5\u20137 days post-implantation. Histology and IHC were used to assess RASF invasion of the cartilage. Flow cytometry was used to understand the homing ability of GMSC in vivo and the incidence of apoptosis of RASF in vitro.\u200b\nResults\n We demonstrate that both GMSC and GMSCExo are potent inhibitors of the deleterious effects of RASF. Both treatments were effective in inhibiting the invasive destructive properties of RASF as well as the potential of these cells to migrate to secondary locations and attack the cartilage. GMSC home to the site of the implant and induce programmed cell death of the RASF.\u200b\nConclusions\n Our results indicate that both GMSC and GMSCExo can block the pathological effects of RASF in this chimeric model of RA. A single dose of either GMSC or GMSCExo can inhibit the deleterious effects of RASF. These treatments can also block the invasive migration of the RASF, suggesting that they can inhibit the spread of RA to other joints. Because the gingival tissue is harvested with little difficulty, relatively small amounts of tissue are required to expand the cells, the simple in vitro expansion process, and the increasing technological advances in the production of therapeutic exosomes, we believe that GMSCExo are excellent candidates as a potential therapeutic for RA.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3121787\/v1","type":"posted-content","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T15:27:04Z","timestamp":1688570824000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Effects of Gingival Mesenchymal Stem Cells and Their Exosomes in a Chimeric Model of Rheumatoid Arthritis"],"prefix":"10.21203","author":[{"given":"Shane","family":"Bruckner","sequence":"first","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria M","family":"Capria","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braden","family":"Zeno","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binnaz","family":"Leblebicioglu","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanu","family":"Goyal","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K","family":"Vasileff","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Awan","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L","family":"Willis","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha P","family":"Ganesan","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael N","family":"Jarjour","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen JS","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha D","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 2018;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/ard-2022-223357","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"82","author":"Sepriano A","year":"2023","unstructured":"Sepriano A, Kerschbaumer A, Bergstra SA, Smolen JS, Van der Heijde D, Caporali R, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2023;82(1):107\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/rheumatology\/ket484","article-title":"Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the disease","volume":"53","author":"Tamas MM","year":"2014","unstructured":"Tamas MM, Filippucci E, Becciolini A, Gutierrez M, Di Geso L, Bonfiglioli K, et al. Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the disease. Rheumatology. 2014;53(6):1100\u20137.","journal-title":"Rheumatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"108794","DOI":"10.1016\/j.intimp.2022.108794","article-title":"An update on novel therapeutic intervention in Rheumatoid arthritis","volume":"109","author":"Shah P","year":"2022","unstructured":"Shah P, Siddique A, Thakkar A, Gharat S, Godad A, Kale P, et al. An update on novel therapeutic intervention in Rheumatoid arthritis. Int Immunopharmacol. 2022;109:108794.","journal-title":"Int Immunopharmacol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102399","article-title":"Prevention and cure: The major unmet needs in the management of rheumatoid arthritis","volume":"110","author":"Mankia K","year":"2020","unstructured":"Mankia K, Di Matteo A, Emery P. Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. J Autoimmun. 2020;110.","journal-title":"J Autoimmun"},{"key":"ref7","article-title":"Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment","volume":"13","author":"Wu D","year":"2022","unstructured":"Wu D, Luo YH, Li T, Zhao XY, Lv T, Fang G, et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022;13.","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102304","article-title":"Targeting fibroblast-like synoviocytes in rheumatoid arthritis","volume":"67","author":"Tsaltskan V","year":"2022","unstructured":"Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022;67.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok B","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065173","article-title":"New Insights into the Role of Synovial Fibroblasts Leading to Joint Destruction in Rheumatoid Arthritis","volume":"24","author":"Matsuda K","year":"2023","unstructured":"Matsuda K, Shiba N, Hiraoka K. New Insights into the Role of Synovial Fibroblasts Leading to Joint Destruction in Rheumatoid Arthritis. Int J Mol Sci. 2023;24(6).","journal-title":"Int J Mol Sci"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010408","article-title":"Metabolic reprogramming in Rheumatoid Arthritis Synovial Fibroblasts: A hybrid modeling approach","volume":"18","author":"Aghakhani S","year":"2022","unstructured":"Aghakhani S, Soliman S, Niarakis A. Metabolic reprogramming in Rheumatoid Arthritis Synovial Fibroblasts: A hybrid modeling approach. Plos Comput Biol. 2022;18(12).","journal-title":"Plos Comput Biol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1381612820666140825122036","article-title":"Role of Synovial Fibroblasts in Rheumatoid Arthritis","volume":"21","author":"Lefevre S","year":"2015","unstructured":"Lefevre S, Meier FMP, Neumann E, Muller-Ladner U. Role of Synovial Fibroblasts in Rheumatoid Arthritis. Curr Pharm Design. 2015;21(2):130\u201341.","journal-title":"Curr Pharm Design"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00011-022-01649-0","article-title":"Immunosenescence of T cells: a key player in rheumatoid arthritis","volume":"71","author":"Gao Y","year":"2022","unstructured":"Gao Y, Cai WW, Zhou Y, Li YH, Cheng JW, Wei F. Immunosenescence of T cells: a key player in rheumatoid arthritis. Inflamm Res. 2022;71(12):1449\u201362.","journal-title":"Inflamm Res"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10753-022-01751-9","article-title":"Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions","volume":"46","author":"Masoumi M","year":"2023","unstructured":"Masoumi M, Alesaeidi S, Khorramdelazad H, Behzadi M, Baharlou R, Alizadeh-Fanalou S, et al. Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions. Inflammation. 2023;46(1):88\u2013102.","journal-title":"Inflammation"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161148","article-title":"The role of dendritic cells and their immunometabolism in rheumatoid arthritis","volume":"14","author":"Suwa Y","year":"2023","unstructured":"Suwa Y, Nagafuchi Y, Yamada S, Fujio K. The role of dendritic cells and their immunometabolism in rheumatoid arthritis. Front Immunol. 2023;14.","journal-title":"Front Immunol"},{"key":"ref16","article-title":"Two Main Cellular Components in Rheumatoid Arthritis: Communication Between T Cells and Fibroblast-Like Synoviocytes in the Joint Synovium","volume":"13","author":"Tu JJ","year":"2022","unstructured":"Tu JJ, Huang W, Zhang WW, Mei JW, Zhu C. Two Main Cellular Components in Rheumatoid Arthritis: Communication Between T Cells and Fibroblast-Like Synoviocytes in the Joint Synovium. Front Immunol. 2022;13.","journal-title":"Front Immunol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar2337","article-title":"Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts","volume":"9","author":"Muller-Ladner U","year":"2007","unstructured":"Muller-Ladner U, Ospelt C, Gay S, Distler O, Pap T. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. Arthritis Res Ther. 2007;9(6):223.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/s101650170027","article-title":"\"Inverse wrap\": an improved implantation technique for virus-transduced synovial fibroblasts in the SCID mouse model for rheumatoid arthritis","volume":"11","author":"Judex M","year":"2001","unstructured":"Judex M, Neumann E, Fleck M, Pap T, Mountz JD, Gay RE, et al. \"Inverse wrap\": an improved implantation technique for virus-transduced synovial fibroblasts in the SCID mouse model for rheumatoid arthritis. Mod Rheumatol. 2001;11(2):145\u201350.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.24331","article-title":"Membrane Type 1 Matrix Metalloproteinase Is a Crucial Promoter of Synovial Invasion in Human Rheumatoid Arthritis","volume":"60","author":"Miller MC","year":"2009","unstructured":"Miller MC, Manning HB, Jain A, Troeberg L, Dudhia J, Essex D, et al. Membrane Type 1 Matrix Metalloproteinase Is a Crucial Promoter of Synovial Invasion in Human Rheumatoid Arthritis. Arthritis Rheum-Us. 2009;60(3):686\u201397.","journal-title":"Arthritis Rheum-Us"},{"issue":"5","key":"ref20","first-page":"1607","article-title":"Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice","volume":"149","author":"MullerLadner U","year":"1996","unstructured":"MullerLadner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996;149(5):1607\u201315.","journal-title":"Am J Pathol"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","article-title":"Synovial fibroblasts spread rheumatoid arthritis to unaffected joints","volume":"15","author":"Lefevre S","year":"2009","unstructured":"Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 2009;15(12):1414\u201320.","journal-title":"Nat Med"},{"key":"ref22","author":"Gan L","year":"2020","unstructured":"Gan L, Liu Y, Cui DX, Pan Y, Zheng LW, Wan M. Dental Tissue-Derived Human Mesenchymal Stem Cells and Their Potential in Therapeutic Application. Stem Cells Int. 2020;2020."},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/1574888X13666180220141114","article-title":"Updates on GMSCs Treatment for Autoimmune Diseases","volume":"13","author":"Huang F","year":"2018","unstructured":"Huang F, Liu ZM, Zheng SG. Updates on GMSCs Treatment for Autoimmune Diseases. Curr Stem Cell Res T. 2018;13(5):345\u20139.","journal-title":"Curr Stem Cell Res T"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2010.01.126","article-title":"Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine","volume":"393","author":"Tomar GB","year":"2010","unstructured":"Tomar GB, Srivastava RK, Gupta N, Barhanpurkar AP, Pote ST, Jhaveri HM, et al. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Bioph Res Co. 2010;393(3):377\u201383.","journal-title":"Biochem Bioph Res Co"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/stem.1638","article-title":"Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses","volume":"32","author":"Yin F","year":"2014","unstructured":"Yin F, Battiwalla M, Ito S, Feng XM, Chinian F, Melenhorst JJ, et al. Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses. Stem Cells. 2014;32(5):1278\u201388.","journal-title":"Stem Cells"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00068","article-title":"Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39-CD73-Adenosine and IDO Signals","volume":"8","author":"Huang F","year":"2017","unstructured":"Huang F, Chen MG, Chen WQ, Gu J, Yuan J, Xue YQ, et al. Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39-CD73-Adenosine and IDO Signals. Front Immunol. 2017;8.","journal-title":"Front Immunol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jcmm.17086","article-title":"Gingival mesenchymal stem cell-derived exosomes are immunosuppressive in preventing collagen-induced arthritis","volume":"26","author":"Tian XH","year":"2022","unstructured":"Tian XH, Wei WM, Cao Y, Ao TR, Huang F, Javed R, et al. Gingival mesenchymal stem cell-derived exosomes are immunosuppressive in preventing collagen-induced arthritis. J Cell Mol Med. 2022;26(3):693\u2013708.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"ref28","article-title":"Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adnosine signal pathway in autoimmune arthritis","volume":"202","author":"Zheng SG","year":"2019","unstructured":"Zheng SG, Luo Y, Wang JL. Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adnosine signal pathway in autoimmune arthritis. J Immunol. 2019;202(1).","journal-title":"J Immunol"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.4049\/jimmunol.0902318","article-title":"Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis","volume":"183","author":"Zhang QZ","year":"2009","unstructured":"Zhang QZ, Shi SH, Liu Y, Uyanne J, Shi YF, Shi ST, et al. Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis. J Immunol. 2009;183(12):7787\u201398.","journal-title":"J Immunol"},{"key":"ref30","author":"Thery C","year":"2006","unstructured":"Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chap. 3:Unit 3 22."},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.4049\/jimmunol.0904068","article-title":"Matrix Metalloproteinase-Dependent Regulation of Rheumatoid Arthritis Synoviocyte Function","volume":"184","author":"Sabeh F","year":"2010","unstructured":"Sabeh F, Fox D, Weiss SJ. Membrane-Type I Matrix Metalloproteinase-Dependent Regulation of Rheumatoid Arthritis Synoviocyte Function. J Immunol. 2010;184(11):6396\u2013406.","journal-title":"J Immunol"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/ar113","article-title":"Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis","volume":"2","author":"Pap T","year":"2000","unstructured":"Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2(5):361\u20137.","journal-title":"Arthritis Res"},{"key":"ref33","article-title":"Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis","volume":"11","author":"Liu H","year":"2020","unstructured":"Liu H, Li RC, Liu T, Yang LY, Yin G, Xie QB. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis. Front Immunol. 2020;11.","journal-title":"Front Immunol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3121787\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3121787\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T16:49:56Z","timestamp":1698684596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3121787\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":33,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3121787\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13075-023-03185-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,7,5]]},"subtype":"preprint"}}